Bruno Julianne, Chief Operating Officer of CRISPR Therapeutics AG ($CRSP), made one open market sale of common shares in the last 365 days, totaling $70,668 on March 21, 2025. This ranks her 10,017th among 11,678 insiders by sale amount, well below the average of $8.6 million across 6.37 transactions per insider. She had no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 23, 2026 | Damora Therapeutics, Inc. | $DMRA | Bruno Julianne | Not found | A | Stock Option (right to buy) | 37313 | $0.00 | 37,313.0000 | 1,327,212 | 9999.99% | 2.81% |
| Feb. 9, 2026 | Damora Therapeutics, Inc. | $DMRA | Bruno Julianne | Not found | M | Series C Preferred Stock | 129 | $0.00 | 0.0000 | 1,327,212 | 100.00% | 0.01% |
| Feb. 9, 2026 | Damora Therapeutics, Inc. | $DMRA | Bruno Julianne | Not found | M | Common Stock | 129000 | $0.00 | 137,032.0000 | 1,327,212 | 1606.08% | 9.72% |
| March 20, 2025 | CRISPR Therapeutics AG | $CRSP | Bruno Julianne | Chief Operating Officer | M | Common Shares | 3750 | $0.00 | 19,346.0000 | 85,774,474 | 24.04% | 0.00% |
| March 21, 2025 | CRISPR Therapeutics AG | $CRSP | Bruno Julianne | Chief Operating Officer | S | Common Shares | 1714 | $41.23 | 17,632.0000 | 85,774,474 | 8.86% | 0.00% |
| March 20, 2025 | CRISPR Therapeutics AG | $CRSP | Bruno Julianne | Chief Operating Officer | M | Restricted Stock Units | 3750 | $0.00 | 11,250.0000 | 85,774,474 | 25.00% | 0.00% |
| March 14, 2025 | CRISPR Therapeutics AG | $CRSP | Bruno Julianne | Chief Operating Officer | A | Stock Option (Right to Buy) | 36666 | $0.00 | 36,666.0000 | 85,774,474 | 9999.99% | 0.04% |
| March 14, 2025 | CRISPR Therapeutics AG | $CRSP | Bruno Julianne | Chief Operating Officer | A | Restricted Stock Units | 27500 | $0.00 | 27,500.0000 | 85,774,474 | 9999.99% | 0.03% |
| March 12, 2025 | CRISPR Therapeutics AG | $CRSP | Bruno Julianne | Chief Operating Officer | S | Common Shares | 190 | $43.32 | 15,596.0000 | 85,774,474 | 1.20% | 0.00% |
| March 10, 2025 | CRISPR Therapeutics AG | $CRSP | Bruno Julianne | Chief Operating Officer | M | Restricted Stock Units | 2399 | $0.00 | 4,796.0000 | 85,774,474 | 33.34% | 0.00% |
| March 11, 2025 | CRISPR Therapeutics AG | $CRSP | Bruno Julianne | Chief Operating Officer | M | Restricted Stock Units | 435 | $0.00 | 0.0000 | 85,774,474 | 100.00% | 0.00% |
| March 11, 2025 | CRISPR Therapeutics AG | $CRSP | Bruno Julianne | Chief Operating Officer | S | Common Shares | 1198 | $42.42 | 15,351.0000 | 85,774,474 | 7.24% | 0.00% |
| March 11, 2025 | CRISPR Therapeutics AG | $CRSP | Bruno Julianne | Chief Operating Officer | M | Common Shares | 435 | $0.00 | 15,786.0000 | 85,774,474 | 2.83% | 0.00% |
| March 10, 2025 | CRISPR Therapeutics AG | $CRSP | Bruno Julianne | Chief Operating Officer | M | Common Shares | 2399 | $0.00 | 16,549.0000 | 85,774,474 | 16.95% | 0.00% |
| Feb. 18, 2025 | CRISPR Therapeutics AG | $CRSP | Bruno Julianne | Chief Operating Officer | M | Common Shares | 650 | $0.00 | 14,483.0000 | 85,774,474 | 4.70% | 0.00% |
| Feb. 18, 2025 | CRISPR Therapeutics AG | $CRSP | Bruno Julianne | Chief Operating Officer | M | Restricted Stock Units | 650 | $0.00 | 650.0000 | 85,774,474 | 50.00% | 0.00% |
| Feb. 19, 2025 | CRISPR Therapeutics AG | $CRSP | Bruno Julianne | Chief Operating Officer | S | Common Shares | 333 | $52.80 | 14,150.0000 | 85,774,474 | 2.30% | 0.00% |
| Oct. 16, 2024 | CRISPR Therapeutics AG | $CRSP | Bruno Julianne | Chief Operating Officer | A | Stock Option (Right to Buy) | 18333 | $0.00 | 18,333.0000 | 0 | 9999.99% | 0.00% |
| June 20, 2024 | CRISPR Therapeutics AG | $CRSP | Bruno Julianne | Chief Operating Officer | M | Restricted Stock Units | 7000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 21, 2024 | CRISPR Therapeutics AG | $CRSP | Bruno Julianne | Chief Operating Officer | S | Common Shares | 3366 | $56.09 | 13,833.0000 | 0 | 19.57% | 0.00% |
| June 20, 2024 | CRISPR Therapeutics AG | $CRSP | Bruno Julianne | Chief Operating Officer | M | Common Shares | 7000 | $0.00 | 17,199.0000 | 0 | 68.63% | 0.00% |
| May 23, 2024 | CRISPR Therapeutics AG | $CRSP | Bruno Julianne | Chief Operating Officer | A | Restricted Stock Units | 20000 | $0.00 | 20,000.0000 | 0 | 9999.99% | 0.00% |